Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive-care units

Infection Control and Hospital Epidemiology

Volumn 17, Issue 4, 1996, Pages 222-226

  Manian, Farrin A ^a,b   Meyer, Lynn ^a   Jenne, Joane ^a   Owen, Amy ^a   Taff, Terry ^a  

^a ST JOHN S MERCY MEDICAL CENTER   (United States)

^b St Johns Mercy Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; GRAM NEGATIVE AEROBIC RODS AND COCCI; HUMAN; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; TIME; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE AEROBIC BACTERIA; HUMANS; INTENSIVE CARE UNITS; MISSOURI; TIME FACTORS;

EID: 0030112927     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141024     Document Type: Article

References (9)

1. Farber BF. Nosocomial infections: an introduction. In: Farber BF, ed. Infection Control in Intensive Care. New York, NY: Churchill Livingstone, Inc; 1987.
2. McGowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-1048.
3. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. NCCLS document M7-A2. 2nd ed. 1988.
4. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-140.
5. Weinstein RA. Epidemiology and control of nosocomial infections in adult intensive care units. Am J Med 1991;91(suppl 3B):179S-183S.
6. Land G, Salgado J, Greenberg RN. Onset of life-threatening ventriculitis during ceftazidime therapy for nosocomial pneumonia due to Enterobacter cloacae. Clin Infect Dis 1993;17:295-296.
7. Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-590.
8. Sanders CC. β-Lactamases of gram-negative bacteria: new challenges for new drugs. Clin Infect Dis 1992;14:1089-1099.
9. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;38:547-557.